US Archives - Page 180 of 223 - European Medical Journal

Prevalence and Impact of Long COVID in the U.S.

NEW data from the 2023 National Health Interview Survey reveal that 8.4% of adults in the U.S. have experienced post-COVID-19 condition.

Frailty Progression Accelerated by Lung Impairments

COPD and preserved ratio impaired spirometry (PRISm) have been identified as key accelerators of frailty progression in older adults in a new study.

Lebrikizumab As Extended Therapy in Chronic Eczema

Patients with moderate-to-severe atopic dermatitis who did not initially meet response criteria for lebrikizumab at 16 weeks can still achieve improvements with continued therapy, according to a recent clinical trial analysis.

Immunotherapy Combination Shows Promise for Early-Stage ERBB2-Positive Breast Cancer

A recent Phase I clinical trial has provided promising results for a novel immunotherapy approach to treat early-stage ERBB2-positive breast cancer.

Pediatric Flu Vaccine: 50% Effectiveness Proven

The consistent effectiveness of influenza vaccines in protecting children from severe flu-related illnesses has been highlighted in recently published findings.

Understanding Cognitive Challenges After Chemotherapy

A recently published systematic review has shed light on chemotherapy-related cognitive impairment (CRCI) and its association with changes in brain connectivity and function.

TNF Inhibitors Lower Fracture Risk in Axial Spondylarthritis

TNF inhibitors reduce fracture risk in axial spondyloarthritis, offering protection against complications from chronic inflammation.

Innovative Psoriasis Trial Boosts Diversity in Clinical Research

The VISIBLE trial sets a benchmark for diversity in psoriasis research, achieving rapid enrollment and valuable data for patients with skin of color.

Socioeconomic Disparities Impact Follow-Up for Pulmonary Nodules

Patients from disadvantaged neighborhoods are less likely to follow guidelines for pulmonary nodule care, highlighting socioeconomic disparities in healthcare access.

Multidrug-Resistant Shigella sonnei Detected in People Experiencing Homelessness

A recent study has revealed an alarming rise in multidrug-resistant Shigella sonnei in Vancouver, Canada among people experiencing homelessness.